Testing effectiveness (Phase 2)Looking for participantsNCT05690048
What this trial is testing
Fecal Microbiota Transfer in Liver Cancer to Overcome Resistance to Atezolizumab/Bevacizumab (FLORA)
Who this might be right for
ImmunotherapyHCC - Hepatocellular Carcinoma
Michael Dill 48